Karyopharm Therapeutics Inc.

IPO

Believers in the Extraordinary | Karyopharm

Public · Newton, United States · Founded 2008 · $104.2M raised

Employees
201–500
Founded
2008
Business Model
B2B
Total Funding
$104.2M
Last Round
$2.0M GrantFeb 2018
Rounds
6
Type
Public

About

Karyopharm Therapeutics is a commercial-stage pharmaceutical company whose core technology centers on inhibition of nuclear export—specifically XPO1—as a mechanism to treat cancer. The company's lead approved medicine, selinexor (XPOVIO), is indicated for relapsed/refractory multiple myeloma and diffuse large B-cell lymphoma, and Karyopharm continues to develop its pipeline across additional blood cancers and solid tumors.

Summary

Karyopharm Therapeutics Inc. is a Biotech company based in Newton, United States, founded in 2008. It has raised $104.2M in total across 6 rounds, most recently a $2.0M Grant round in Feb 2018. Investors include Chione Ltd, SVB Leerink and Foresite Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Feb 2018
$2.0M

Sign up to see all 7 rounds

Series A through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Karyopharm Therapeutics Inc. on Indexed.vc
<a href="https://indexed.vc/companies/karyopharm-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/karyopharm-therapeutics-inc" alt="Karyopharm Therapeutics Inc. on Indexed.vc" width="260" height="76" /></a>